SK284990B6 - Monohydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents

Monohydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDF

Info

Publication number
SK284990B6
SK284990B6 SK1489-2001A SK14892001A SK284990B6 SK 284990 B6 SK284990 B6 SK 284990B6 SK 14892001 A SK14892001 A SK 14892001A SK 284990 B6 SK284990 B6 SK 284990B6
Authority
SK
Slovakia
Prior art keywords
monohydrate
compound
hydrochloride monohydrate
hydrochloride
pyridyl
Prior art date
Application number
SK1489-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK14892001A3 (sk
Inventor
Paul David James Blackler
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK14892001A3 publication Critical patent/SK14892001A3/sk
Publication of SK284990B6 publication Critical patent/SK284990B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK1489-2001A 1999-04-20 2000-04-19 Monohydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie SK284990B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001527 WO2000063206A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (2)

Publication Number Publication Date
SK14892001A3 SK14892001A3 (sk) 2002-02-05
SK284990B6 true SK284990B6 (sk) 2006-04-06

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1489-2001A SK284990B6 (sk) 1999-04-20 2000-04-19 Monohydrát hydrochloridu 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie

Country Status (42)

Country Link
EP (2) EP1411054A1 (cs)
JP (2) JP4283450B2 (cs)
KR (1) KR100677815B1 (cs)
CN (2) CN1327446A (cs)
AP (1) AP1680A (cs)
AR (2) AR023563A1 (cs)
AT (1) ATE262524T1 (cs)
AU (1) AU773112B2 (cs)
BG (1) BG65428B1 (cs)
BR (1) BR0009898A (cs)
CA (1) CA2370270A1 (cs)
CO (1) CO5170420A1 (cs)
CZ (1) CZ300934B6 (cs)
DE (1) DE60009276T2 (cs)
DK (1) DK1173437T3 (cs)
DZ (1) DZ3163A1 (cs)
EA (1) EA004769B1 (cs)
EG (1) EG23946A (cs)
ES (1) ES2214267T3 (cs)
GB (1) GB9909075D0 (cs)
HK (1) HK1045304B (cs)
HR (1) HRP20010771B1 (cs)
HU (1) HUP0200785A3 (cs)
IL (1) IL146077A0 (cs)
MA (1) MA26784A1 (cs)
MX (1) MXPA01010695A (cs)
MY (1) MY125209A (cs)
NO (1) NO320573B1 (cs)
NZ (1) NZ515164A (cs)
OA (1) OA11867A (cs)
PE (1) PE20010047A1 (cs)
PL (1) PL351115A1 (cs)
PT (1) PT1173437E (cs)
RS (1) RS50137B (cs)
SI (1) SI1173437T1 (cs)
SK (1) SK284990B6 (cs)
TR (1) TR200103041T2 (cs)
TW (1) TWI291463B (cs)
UA (1) UA72245C2 (cs)
UY (1) UY26113A1 (cs)
WO (1) WO2000063206A2 (cs)
ZA (1) ZA200108721B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DK1448559T3 (da) * 2001-11-21 2007-04-30 Smithkline Beecham Plc 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
HK1045304A1 (en) 2002-11-22
AP1680A (en) 2006-11-27
BR0009898A (pt) 2002-04-16
NO320573B1 (no) 2005-12-27
YU81601A (sh) 2004-09-03
JP4283450B2 (ja) 2009-06-24
HUP0200785A2 (en) 2002-08-28
JP2002542243A (ja) 2002-12-10
GB9909075D0 (en) 1999-06-16
DE60009276T2 (de) 2004-08-26
HUP0200785A3 (en) 2004-03-29
RS50137B (sr) 2009-03-25
HRP20010771B1 (en) 2005-06-30
ZA200108721B (en) 2002-09-13
CA2370270A1 (en) 2000-10-26
TR200103041T2 (tr) 2002-03-21
CN1327446A (zh) 2001-12-19
DE60009276D1 (de) 2004-04-29
AR023563A1 (es) 2002-09-04
CN101125851A (zh) 2008-02-20
JP2009161544A (ja) 2009-07-23
PT1173437E (pt) 2004-06-30
WO2000063206A2 (en) 2000-10-26
WO2000063206A3 (en) 2001-02-22
KR20010112446A (ko) 2001-12-20
OA11867A (en) 2006-03-02
EG23946A (en) 2008-01-22
EP1411054A1 (en) 2004-04-21
CZ20013758A3 (cs) 2003-05-14
HRP20010771A2 (en) 2002-12-31
MXPA01010695A (es) 2002-06-04
UA72245C2 (uk) 2005-02-15
CZ300934B6 (cs) 2009-09-16
EP1173437B1 (en) 2004-03-24
EP1173437A2 (en) 2002-01-23
MA26784A1 (fr) 2004-12-20
AP2001002332A0 (en) 2001-12-31
AR023567A1 (es) 2002-09-04
AU4131100A (en) 2000-11-02
PL351115A1 (en) 2003-03-24
TWI291463B (en) 2007-12-21
SI1173437T1 (en) 2004-06-30
UY26113A1 (es) 2000-12-29
BG106120A (en) 2002-05-31
NO20015105L (no) 2001-12-19
ATE262524T1 (de) 2004-04-15
CO5170420A1 (es) 2002-06-27
EA004769B1 (ru) 2004-08-26
KR100677815B1 (ko) 2007-02-05
BG65428B1 (bg) 2008-07-31
NZ515164A (en) 2004-02-27
PE20010047A1 (es) 2001-03-10
ES2214267T3 (es) 2004-09-16
NO20015105D0 (no) 2001-10-19
EA200101102A1 (ru) 2002-04-25
AU773112B2 (en) 2004-05-20
MY125209A (en) 2006-07-31
HK1045304B (zh) 2004-12-24
IL146077A0 (en) 2002-07-25
SK14892001A3 (sk) 2002-02-05

Similar Documents

Publication Publication Date Title
US6815457B1 (en) Thiazolidinedione derivative and its use as antidiabetic
SK286422B6 (sk) Hydrát 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jehovýroby, farmaceutický prípravok s jeho obsahom a jeho použitie
SK286427B6 (sk) Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
JP2009143954A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
EP1045847A1 (en) Hydrate of 5- 4- 2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt
JP2009161544A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
AU2754902A (en) Novel pharmaceutical

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110419